The incidence of type 2 diabetes is rising rapidly worldwide, mainly due to the increase in the incidence of obesity. Both obesity and type 2 diabetes are complex genetic traits, but they share some non-genetic risk factors. Hence, it is tempting to speculate that susceptibility to type 2 diabetes and obesity may also involve shared underlying genetic factors acting on common molecular mechanisms. Recent genome-wide association (GWA) studies identified 17 common loci for obesity and 19 common loci for type 2 diabetes. This article explores whether the susceptibility loci for type 2 diabetes and obesity can indicate potential overlapping mechanisms in the disorders.
conditions are characterised by insulin resistance, suggesting a shared pathology. It has been proposed that susceptibility to developing type 2 diabetes and obesity is, in part, due to shared underlying genetic factors involved in common molecular mechanisms. This article explores the genes recently identified for type 2 diabetes and obesity by genome-wide association studies (GWAS) and evaluates their functions in an effort to determine whether there is any support for the hypothesis that type 2 diabetes and obesity share some underlying mechanism(s).
Common Type 2 Diabetes and Obesity Susceptibility Loci
Before the era of GWAS, genes were prioritised as candidate disease genes because of their function and/or position, and they were then studied for association with obesity and type 2 diabetes. These approaches had limited success, as replication of associated genes proved possible only for variants in or near PPARG, KCNJ11, TCF2
and WFS1 with type 2 diabetes 2 and for variants in or near BDNF, MC4R and SH2B1 with obesity. Recently, a number of GWAS have identified 17 common loci for obesity and 19 common loci for type 2 diabetes (see Tables 1 and 2) . [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] An interesting finding is that the results of GWAS often point towards genes with currently unknown or poorly described functions. This is one of the reasons why the previous approaches to gene hunting had limited success. Most of the recently identified genes were not tested for association simply because their biological functions were unknown and they were not therefore suspected of being involved in the disease. 
Functions of Type 2 Diabetes and Obesity Genes
The susceptibility loci for obesity and type 2 diabetes can provide insight into the aetiology of the traits, yet it is difficult to link genetic associations to biological mechanisms. It is important to keep in mind that most of the observed associations are located in noncoding regions of the genome and that the presented type 2 diabetes and obesity genes are mostly genes near the associated markers. We assume that at least some of these nearby genes are truly involved in the traits as we discuss the function of these genes to gain more insight into the disease pathology.
Type 2 Diabetes
The main feature of type 2 diabetes is the inability of an individual to maintain proper blood glucose levels. The key player in this homeostasis is the peptide hormone insulin, which is produced in the β cells of the pancreas. After a meal this hormone is released into the bloodstream and transported to its several target tissues,
where it diminishes hepatic glucose output and triggers glucose uptake and storage as either fat or glycogen. Type 2 diabetes starts with the failure of several tissues, such as adipose tissue and muscle, to respond to the stimulus of insulin (this is often referred to as insulin resistance). As a result, insulin levels rise and it is presumed that, after a certain time, β cells are not able to keep up with the growing demands for insulin release. At this point a (second) vicious cycle of higher blood glucose levels and a higher demand for insulin is entered, which increases the strain on the β cells and leads to β-cell apoptosis and, ultimately, a complete inability to produce insulin. 15 The type 2 diabetes risk variants currently pinpointed appear to act through interference with β-cell insulin secretion rather than and TMEM18 are involved in neural development, 11, 13 whereas NPC1 is involved in endosomal cholesterol trafficking in the central nervous system, liver and macrophages. 22 Because satiation signals influence how many calories are eaten during individual meals, it is interesting to further explore the effect of obesity susceptibility variants on total and nutrient-specific dietary intake. Although total energy intake is a vital aspect of food intake, macronutrient composition or diet patterns may be equally important factors underlying the development of obesity. Common variants near the FTO and MC4R genes were recently found to be associated with total energy intake, and a variant near MC4R was also found to be associated with dietary fat. [23] [24] [25] In addition, in a study population of 1,700 Dutch females, the susceptibility loci near NEGR1, TMEM18, BDNF, MTCH2 and SH2B1 showed association with macronutrient intake. 26 It can be argued that the genes associated with food intake play a role in satiation signalling.
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Further insight into the function of these genes may yield valuable clues for lifestyle intervention and therapeutics.
Genome-wide Association Studies Give Insight into Shared Disease Aetiology
So far, results from the recent GWA studies do not point towards obesity and type 2 diabetes having an increased risk from shared disease susceptibility loci. It seems that the susceptibility genes for obesity are involved at the start of the trait (energy imbalance) and those for type 2 diabetes at a later stage of the disease (β-cell defect).
The initial finding of association between the FTO gene and type 2 diabetes was subsequently shown to be entirely due to an obesity risk. The gene was found to be highly associated with type 2 diabetes in several study populations 27 but failed to replicate in studies where they matched the cases and controls on BMI or selected relatively lean cases. 7, 9 The loci near GNPDA2, BDNF and TMEM18 that were associated with obesity were also found to be weakly associated with type 2 diabetes. 11, 13 Follow-up studies should explore whether these associations with type 2 diabetes mainly act through an effect on weight regulation. They need to take into account not only BMI but also other measures of obesity.
Recently, it has become clear that not only is the amount of body fat important but especially its distribution in determining disease risk. Independently of BMI, a larger waist circumference (as a measure of abdominal obesity) is related to chronic disease risk, such as type 2 diabetes. 28 However, because there are still many more obesity and type 2 diabetes genes to discover, we cannot rule out that the susceptibility for developing type 2 diabetes and obesity is partly due to shared underlying genetic factors.
In a previous study we compared all the published genome scans for type 2 diabetes and obesity and identified five overlapping chromosomal regions for both entities. 29 However, the shared genetic effect may be smaller than we initially thought, or obesity could simply be a non-genetic risk factor for type 2 diabetes because it provokes insulin resistance.
Follow-up of Confirmed Associations and Alternative Gene-hunting Approaches
The next challenge is to go from the statistical association of the markers to a functional link between the genomic region and type 2 diabetes and obesity. The associated single nucleotide polymorphism (SNP) will either be the disease-causing variant or strong linkage disequilibrium (LD) with the causal variant, i.e. the associated SNP and the causal variant are inherited together.
Re-sequencing of the susceptibility loci is needed to establish the causal genes. This will be a daunting task because the LD blocks can
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